Larvol Delta - Atossa-Therapeutics-Inc-Receives-Authorization-from-FDA-to-Initiate-its-Phase-2-Study-of-Neoadjuvant-Zendoxifen-in-Premenopausal-Women-with-ERHER2-Breast-Cancer

Z-endoxifen - Atossa Therap

https://www.globenewswire.com/news-release/2022/10/24/2540074/0/en/Atossa-Therapeutics-Inc-Receives-Authorization-from-FDA-to-Initiate-its-Phase-2-Study-of-Neoadjuvant-Z-endoxifen-in-Premenopausal-Women-with-ER-HER2-Breast-Cancer.html

Oct 24, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next